4.250USD-1.16%Mkt Cap: 102.68M $P/E: —1d ago
Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and m…
Industry Peers
Diagnostics & Research$201.86BUSDP/E 29.8
$145.10BUSDP/E 39.7
$45.26BUSDP/E 43.7
$45.44BUSDP/E 42.4
$38.64BUSD
$38.44BUSDP/E 27.3
$37.13BUSDP/E 48.1
$35.13BUSDP/E 26.2
$28.78BUSDP/E 34.6
$26.98BUSDP/E 31.4
$23.18BUSDP/E 23.1
$23.12BUSDP/E 25.0
$20.55BUSD
$15.36BUSDP/E 33.9
$13.21BUSDP/E 27.6
$12.46BUSDP/E 53.7
$11.04BUSD
$9.40BUSDP/E 22.0
$5.90BUSDP/E 237.4
$5.68BUSD
$5.21BUSDP/E 44.6
$4.95BUSD
$4.73BUSDP/E 54.8
$3.73BUSDP/E 26.3
$3.54BUSD
$3.09BUSD
$2.08BUSD
$1.93BUSD
$1.70BUSDP/E 43.3
$1.83BUSD
$1.63BUSD
$1.46BUSDP/E 22.1
$996.45MUSDP/E 20.9
$898.56MUSD
$734.89MUSD
$653.57MUSDP/E 42.6
$584.63MUSD
$583.63MUSD
$292.59MUSDP/E 2.9
$292.75MUSD
$206.70MUSD
$152.09MUSD
$137.57MUSD
$97.25MUSD
$89.37MUSDP/E 17.2
$81.49MUSD
$58.55MUSD
$42.32MUSD
$31.26MUSD
$26.61MUSD
$18.32MUSD
$16.60MUSD
$11.89MUSD
$9.94MUSD
$8.70MUSD
$8.87MUSD
$7.24MUSD
$6.69MUSD
$5.83MUSD
$5.57MUSD
$5.06MUSD
$4.47MUSD
$4.44MUSD
$3.29MUSD
$3.18MUSD
$2.70MUSD
$869.0KUSD
$314.2KUSDP/E Infinity
$19.6KUSD
Indicators:|
Key Statistics
Company
Market Cap102.68M $
Enterprise Value109.52M $
Revenue (TTM)68.38M $
Gross Profit38.80M $
Net Income (TTM)-19.95M $
Revenue/Share2.988 USD
Last Price4.250 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees216
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS30068X1037
Valuation
P/E (Trailing)—
P/E (Forward)-9.88
PEG—
EV/EBITDA-9.25
EV/Revenue1.60
P/S1.50
P/B7.10
EPS (TTM)-0.90
EPS (Forward)-0.43
52W Range
2.59017% of range12.23
52W High12.23 USD
52W Low2.590 USD
Profitability
Gross Margin58.28%
Oper. Margin-19.73%
EBITDA Margin-17.32%
Profit Margin-29.97%
ROE-114.34%
ROA-34.39%
Growth
Revenue Growth11.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.63M $
CapEx (TTM)641.00K $
FCF Margin-13.26%
FCF Yield-8.83%
Net Debt5.63M $
Net Debt/EBITDA-0.48
Balance Sheet
Debt/Equity1.47
Current Ratio3.47
Quick Ratio2.97
Book Value/Sh0.5990 USD
Cash/Share0.8900 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.571 USD
Upside (mean)+101.7%
Target Range8.000 USD – 10.00 USD
$8.000+101.7% to mean$10.00
# Analysts7
Ownership
Shares Out.24.16M
Float13.81M
Insiders27.91%
Institutions52.63%
Short Interest
Short Ratio2.8d
Short % Float3.72%
Short % Out.3.37%
Shares Short813.37K
Short (prev mo.)864.74K
Technical
SMA 504.259 (-0.2%)
SMA 2005.645 (-24.7%)
Beta2.02
S&P 52W Chg20.25%
Avg Vol (30d)243.17K
Avg Vol (10d)220.81K
Technical Indicators
RSI (14)47.3
MACD0.0045
MACD Signal0.0725
MACD Hist.-0.0680
BB Upper4.862 USD
BB Middle4.473 USD
BB Lower4.084 USD
BB Width17.39%
ATR (14)0.3309 USD
Vol Ratio (20d)0.84x